0001883516-21-000001.txt : 20210917 0001883516-21-000001.hdr.sgml : 20210917 20210917172107 ACCESSION NUMBER: 0001883516-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210917 DATE AS OF CHANGE: 20210917 EFFECTIVENESS DATE: 20210917 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Cambium Biomaterials, Inc. CENTRAL INDEX KEY: 0001883516 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-413834 FILM NUMBER: 211261349 BUSINESS ADDRESS: STREET 1: 626 BANCROFT WAY, SUITE A CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: (212) 792-6966 MAIL ADDRESS: STREET 1: 626 BANCROFT WAY, SUITE A CITY: BERKELEY STATE: CA ZIP: 94710 D 1 primary_doc.xml X0708 D LIVE 0001883516 Cambium Biomaterials, Inc. 626 BANCROFT WAY, SUITE A BERKELEY CA CALIFORNIA 94710 (415) 878-3752 DELAWARE None None Corporation true 2019 SIMON WADDINGTON C/O 626 BANCROFT WAY, SUITE A BERKELEY CA CALIFORNIA 94710 Executive Officer Director STEPHAN HERRERA C/O 626 BANCROFT WAY, SUITE A BERKELEY CA CALIFORNIA 94710 Executive Officer Director FRANCISCO GIMENEZ C/O 626 BANCROFT WAY, SUITE A BERKELEY CA CALIFORNIA 94710 Director ANDREW GUENTHNER C/O 626 BANCROFT WAY, SUITE A BERKELEY CA CALIFORNIA 94710 Executive Officer Other Technology Decline to Disclose 06b false 2021-09-02 false true false 0 28014379 8012877 20001502 TOTAL OFFERING AMOUNT AND TOTAL AMOUNT SOLD INCLUDES CONVERSION OF PREVIOUSLY ISSUED CONVERTIBLE SECURITIES. false 3 0 0 0 false Cambium Biomaterials, Inc. /s/ Simon Waddington Simon Waddington Chief Executive Officer 2021-09-14